This week, we have conversations with Cosmo Feilding Mellen, CEO of Beckley Psytech; Sirli Rosenvald, CEO of Estonian company Funki, and Per von Mentzer, CEO of Swedish company PharmNovo. We spoke with Funki at Life Sciences Baltics in Vilnius, Lithuania, recently, and with von Mentzer at NLS Days in Gothenburg.

Taking on pain

PharmNovo AB is a biotechnology company headquartered at Medicon Village in Lund, Sweden. Founded in 2008, it specialises in the development of novel treatments for neuropathic pain, a condition that affects millions of patients worldwide and remains difficult to manage.

The company’s lead candidate, PN6047, is a selective delta opioid receptor agonist. Preclinical studies have indicated analge ...